Group 1 - Libet has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds, valid for 12 months [1] - Dinglong plans to acquire an additional 8% stake in its subsidiary, increasing its ownership from 91.35% to 99.35% for a total price of 240 million yuan [1] - Longyuan Donggu has been designated as a supplier for a major automotive project, with an expected total sales amount of 450 to 500 million yuan over five years [14] Group 2 - Luoniushan reported a sales revenue of 100 million yuan in May, a year-on-year decrease of 11.45% [2] - Baoming Technology has secured a loan commitment of up to 7 million yuan for stock repurchase [2] - Xinhua Pharmaceutical has received approval for the listing of a new chemical raw material used in treating chronic heart failure and hypertension [3] Group 3 - China Minmetals announced a new contract amount of 396 billion yuan for the first five months of the year, a decrease of 22.2% year-on-year [7] - Zhongbei Communication's application for a specific stock issuance has been accepted by the Shanghai Stock Exchange [8] - Rongfa Nuclear Power plans to issue bonds not exceeding 1 billion yuan to repay debts and supplement working capital [9] Group 4 - Phoenix Optical plans to invest 8.5 million USD to establish a wholly-owned subsidiary in Vietnam for manufacturing optical products [11] - Xiamen Airport reported a passenger throughput of 2.4752 million in May, a year-on-year increase of 8.34% [12] - Weilan Biological has received a new veterinary drug registration certificate for a product aimed at treating canine allergies and inflammation [13] Group 5 - Shouxiangu has completed the registration of a health food product that claims to enhance immunity [13] - Xingye Yinxin's subsidiary has passed a resource reserve verification report, confirming significant mineral reserves [16] - Shaanxi Construction has won two major projects with a total contract value exceeding 2.8 billion yuan [18] Group 6 - Huari received a cash dividend of 50 million yuan from its subsidiary [20] - Zhongchu's deputy general manager has resigned due to governance arrangements [21] - Kexin Pharmaceutical's core product has received breakthrough therapy designation from the National Medical Products Administration [39]

本公司及董事会全体成员保证公告内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2025 年 5 月份生猪销售情况 证券代码：000735 证券简称：罗牛山 公告编号：2025-022 罗牛山股份有限公司 2025 年 5 月畜牧行业销售简报 （一）上述披露仅包含公司生猪养殖业务销售情况，不含其它业务。 （二）生猪市场价格的大幅波动（下降或上升），都可能会对公司的 经营业绩产生重大影响，敬请广大投资者审慎决策，注意投资风险。 （三）生猪市场价格变动的风险是整个生猪生产行业的系统风险，对 任何一家生猪生产者来说，都是客观存在的、不可控制的外部风险。 三、其他提示 公司 2025 年 5 月销售生猪 5.84 万头，环比下降 10.41%,同比下降 9.52%；销售收入 10,044.69 万元，环比下降 19.60%，同比下降 11.45%。 2025 年 1-5 月，公司累计销售生猪 26.64 万头，同比下降 17.88%； 累计销售收入 51,760.17 万元，同比下降 2.18%。 上述数据未经审计，与定期报告披露的数据可能存在差异，因此上述 数据仅作为阶段性数据供投资者参考。 二、 ...

Group 1 - The core point of the article is that Longyuan Mountain reported a decline in both pig sales and revenue for May 2025, indicating a challenging market environment [1] - In May 2025, the company sold 58,400 pigs, which represents a month-on-month decrease of 10.41% and a year-on-year decrease of 9.52% [1] - The sales revenue for May 2025 was 100 million yuan, reflecting a month-on-month decline of 19.60% and a year-on-year decline of 11.45% [1] Group 2 - For the period from January to May 2025, the cumulative sales of pigs reached 266,400, showing a year-on-year decrease of 17.88% [1] - The cumulative sales revenue for the same period was 518 million yuan, which is a year-on-year decline of 2.18% [1]

Market Overview - The Shanghai Composite Index rose by 0.43% on June 9, with 30 industries experiencing gains, led by the pharmaceutical and agricultural sectors, which increased by 2.30% and 1.72% respectively [1] - The food and beverage sector was the biggest loser, declining by 0.43% [1] Capital Flow Analysis - The net inflow of capital in the two markets was 3.537 billion yuan, with 16 industries seeing net inflows [1] - The non-bank financial sector had the largest net inflow of 2.781 billion yuan, rising by 1.20% [1] - The pharmaceutical sector also saw significant inflows, with a net inflow of 2.027 billion yuan and a daily increase of 2.30% [1] Agricultural Sector Performance - The agricultural sector rose by 1.72%, despite a net outflow of 475 million yuan [2] - Out of 103 stocks in this sector, 81 rose while 15 fell, with one stock hitting the daily limit down [2] - Notable inflows included stocks like Nuo Shun, which saw a net inflow of 71.3476 million yuan, followed by Pingtan Development and Tangrenshen with inflows of 18.2354 million yuan and 12.1950 million yuan respectively [2] Top Stocks in Agricultural Sector - The top stocks with significant capital inflows included: - Nuo Shun: +5.62%, 71.3476 million yuan inflow [3] - Pingtan Development: +0.98%, 18.2354 million yuan inflow [3] - Tangrenshen: +1.04%, 12.1950 million yuan inflow [3] Stocks with Capital Outflows in Agricultural Sector - The stocks with the largest capital outflows included: - Muyuan Foods: -4.11%, 173.1375 million yuan outflow [5] - Ronow: -3.28%, 77.2356 million yuan outflow [5] - Andeli: -10.01%, 52.2715 million yuan outflow [5]

Group 1 - The Hainan Free Trade Zone concept rose by 1.65%, ranking 10th among concept sectors, with 21 stocks increasing in value, led by Luoniushan, Hainan Ruize, and Hainan Gaosu, which rose by 8.36%, 7.49%, and 5.33% respectively [1][2] - The concept sector saw a net inflow of 5.11 billion yuan, with 21 stocks receiving net inflows, and 10 stocks exceeding 30 million yuan in net inflow, with Luoniushan leading at 1.62 billion yuan [2][3] - The net inflow ratios for Luoniushan, Hainan Gaosu, and Hainan Ruize were 21.45%, 18.96%, and 17.61% respectively, indicating strong investor interest [3] Group 2 - The top gainers in the Hainan Free Trade Zone concept included Luoniushan, Hainan Gaosu, and Hainan Ruize, while the top losers were Lishang Guochao, Hainan Huatie, and ST Huluwa, which fell by 2.09%, 2.00%, and 0.72% respectively [1][5] - The trading volume and turnover rates for leading stocks in the Hainan Free Trade Zone concept were notable, with Luoniushan having a turnover rate of 10.85% and Hainan Ruize at 11.83% [3][4]

泰和泰（海口）律师事务所 关于罗牛山股份有限公司 2024 年年度股东大会 法 律 意 见 书 致：罗牛山股份有限公司 泰和泰（海口）律师事务所（以下简称"本所"）接受罗牛山股 份有限公司（以下简称"公司"）的委托，指派张宁、杨媛律师出席 公司 2024 年年度股东大会（以下简称"本次股东大会"）。本所律 师依据《中华人民共和国公司法》、《中华人民共和国证券法》、《上 市公司股东大会规则》、公司章程以及律师行业公认的业务标准，对 公司本次股东大会的召集和召开程序、出席会议人员的资格、表决方 式、表决程序的合法性、有效性进行了认真的审查，现出具法律意见 如下： 一、本次大会的召集、召开程序 公司董事会决定于 2025 年 5 月 23 日召开公司 2024 年年度股东 大会，并于 2025 年 4 月 26 日在《中国证券报》、《证券时报》及巨 潮资讯网上刊登本次大会的通知（公告编号：2025-017）。本次大会 现场会议于 2024 年 5 月 23 日下午 14:55 在海口市美兰区国兴大道 5 号海南大厦农信楼 12 楼公司 1216 会议室召开。 网络投票时间为：通过深圳证券交易所交易系统投票的时间为 ...

证券代码：000735 证券简称：罗牛山 公告编号：2025-021 罗牛山股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更前次股东大会决议的情形。 一、会议召开和出席情况 罗牛山股份有限公司 2024 年年度股东大会于 2025 年 05 月 23 日 下午 14：55 在公司十二楼 1216 会议室召开。本次会议以现场投票与 网络投票相结合的方式召开。会议召开符合《公司法》、《股票上市规 则》和《公司章程》的有关规定。 出席本次会议的股东（代理人）共 515 人，代表股份 264,154,751 股，占总股本的 22.9398% 。其中，出席现场会议的股东(代理人) 4 人，代表股份 246,732,522 股，占公司有表决权总股份的 21.4268%； 通过网络投票的股东 511 人，代表股份 17,422,229 股，占公司有表 决权总股份的 1.5130％。 董事长徐自力先生因工作原因无法现场出席本次股东大会，根据 《公司章程》的 ...

Core Viewpoint - The animal vaccine sector has shown a significant increase, with a 4.00% rise, ranking third among concept sectors, driven by notable gains in several stocks [1][2]. Group 1: Sector Performance - As of May 20, the animal vaccine concept increased by 4.00%, with 19 stocks rising, including *ST Xianfeng, which hit the daily limit, and others like Kexing Pharmaceutical, Ruipu Biological, and Kanghua Biological, which rose by 15.56%, 8.41%, and 6.70% respectively [1][2]. - The animal vaccine sector was among the top-performing sectors, alongside cultivated diamonds and pet economy, which rose by 4.10% and 4.08% respectively [2]. Group 2: Capital Inflow - The animal vaccine sector saw a net inflow of 67 million yuan, with 13 stocks receiving net inflows, and 6 stocks attracting over 10 million yuan in net inflows [2]. - Jinhe Biological led the net inflow with 36.88 million yuan, followed by Kexing Pharmaceutical, Dabeinong, and Plk, which received net inflows of 15.38 million yuan, 13.79 million yuan, and 13.60 million yuan respectively [2][3]. Group 3: Capital Flow Ratios - Stocks such as *ST Xianfeng, Kexing Pharmaceutical, and KQ Biotech had the highest net inflow ratios, at 14.17%, 6.56%, and 5.52% respectively [3]. - The top stocks in terms of capital inflow included Jinhe Biological with a turnover rate of 18.22% and a daily increase of 4.40%, and Kexing Pharmaceutical with a turnover rate of 3.46% and a daily increase of 15.56% [3][4].

证券代码：000735 证券简称：罗牛山 公告编号：2025-020 罗牛山股份有限公司 关于召开 2024 年年度股东大会的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 罗牛山股份有限公司（以下简称"公司"）于 2025 年 4 月 26 日 在《中国证券报》 、《证券时报》和巨潮资讯网（www.cninfo.com.cn） 上刊登了《关于召开 2024 年年度股东大会的通知》(公告编号：2025- 据相关规定，现发布关于召开 2024 年年度股东大会的提示性公告。 一、召开会议基本情况 （3）公司聘请的律师。 公司 1216 会议室。 二、会议审议事项 法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 （1）现场会议时间：2025 年 05 月 23 日（周五）下午 14:55 （2）网络投票时间：通过深交所交易系统进行网络投票的具体 时间为：2025 年 05 月 23 日（周五）交易时间，即 9:15—9:25，9:30— （http://wltp.cninfo.com.cn）进行网络投票的具体时间为：2025 年 05 月 2 ...

证券代码：000735 证券简称：罗牛山 公告编号：2025-020 罗牛山股份有限公司 关于召开 2024 年年度股东大会的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 罗牛山股份有限公司（以下简称"公司"）于 2025 年 4 月 26 日 在《中国证券报》、《证券时报》和巨潮资讯网（www.cninfo.com.cn） 上刊登了《关于召开 2024 年年度股东大会的通知》(公告编号：2025- 017)。本次股东大会采取现场投票与网络投票相结合的方式召开。根 据相关规定，现发布关于召开 2024 年年度股东大会的提示性公告。 一、召开会议基本情况 1、股东大会届次：2024 年年度股东大会。 2、股东大会的召集人：董事会。 3、会议召开的合法、合规性：本次股东大会会议召开符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 4、会议召开的日期、时间： （1）现场会议时间：2025 年 05 月 23 日（周五）下午 14:55 （2）网络投票时间：通过深交所交易系统进行网络投票的具体 时间为：2025 年 05 月 23 日 ...